Promoter Vikram Vuppala has confirmed that no encumbrance was created on the shares of nephrocare health services during the financial year ended March 31, 2026. The declaration, submitted to the stock exchanges, assures stakeholders that the shares remain free from new charges or liens, other than those already disclosed. This disclosure provides transparency regarding the financial standing of the promoter's holdings in Nephrocare Health Services Limited.

The confirmation was made in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Vikram Vuppala, along with persons acting in concert, stated that no direct or indirect encumbrance has been created on the shares during the specified period. The filing was addressed to BSE Limited and the National Stock Exchange of India Limited to ensure the information is on public record.

Copies of the declaration were sent to the Audit Committee and the Company Secretary and Compliance Officer of Nephrocare Health Services Limited for their internal records and necessary action. The company is formerly known as Nephrocare Health Services Private Limited.

Nephrocare Health Services disclosed that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services Philippines Inc., has acquired assets of a dialysis center for PhP 32,640,000. The acquisition, executed through an Asset Transfer Agreement (ATA) dated June 09, 2026, involves the purchase of identified assets from Amica Healthcare System Corporation located at Dona Soledad, Don Bosco, Paranaque City, Philippines. This strategic expansion strengthens the company's footprint in the dialysis care segment within the international healthcare market.

Transaction Details

The agreement was entered into between Nephrocare Health Care Services Philippines Inc. (Purchaser) and Amica Healthcare System Corporation (Seller). The disclosure was made to the exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Key details of the transaction are outlined below:

Key Disclosures

The filing confirmed that the seller is not related to the promoter or promoter group of the company. Consequently, the transaction does not qualify as a related party transaction and was conducted at arm's length. There are no special rights, such as the right to appoint directors or restrict capital structure changes, attached to the agreement. The acquisition marks a significant step in Nephrocare Health Services' operational growth within the international healthcare market.